20 results
Pain Assessment and Management Initiative (PAMI) - Opioid Prescribing and Equianalgesic Chart - Agents and Dosing

#Management
Equianalgesic Chart - Agents ... and Dosing #Management ... Equianalgesics #Conversion ... #Doses #Dosing ... #Table #PAMI
Angiotensin Receptor Blockers 
Recommended Dose Conversions 

Valsartan 
Irbesartan 
Losartan 
Olmesartan 
Telmisartan 
Candesartan 
Azilsartan 
Eprosartan 

A few
Conversions ... initiating an ARB ... Receptor #Blockers #ARB ... #Conversion #Table ... #Dosing #Pharmacology
ANGIOTENSIN II RECEPTOR ANTAGONIST (ARB) DOSING:
TOOL FOR SWITCHING BETWEEN AGENTS IN CANADA
The information provided is intended
) DOSING: TOOL ... an alternative agent ... Doses should be ... #Pharmacology #Conversion ... Switching #Equivalent #Table
Phosphate binders - quick reference chart of maximum daily dose. Most patients with CKD will require
phosphate binding agents ... since they are ... not able to effectively ... Note not listed are ... #Dosing #Pharmacology
Angiotensin II Receptor Blocker (ARB) - Comparable Dose Chart 
 - Valsartan (Diovan®) 40 mg daily
Receptor Blocker (ARB ... ) - Comparable Dose ... #Equivalent #Conversion ... #Dosing #Doseage ... #Table #AngiotensinII
CA-Bridge Buprenorphine Hospital Quick Start Algorithm - Management of acute opiate withdrawal 
 - Any prescriber
If patient is stable ... as first-line treatment ... Buprenorphine Dosing ... sublingual (SL) are ... try Bup 0.3mg IV/IM
PDE5 inhibitors are usually the drugs of first choice for erectile dysfunction.

PDE5 inhibitors enhance an erection that is
PDE5 inhibitors are ... e.g. at lower doses ... pharmacology #comparison #treatment ... #medications #dosing ... #drugs #table #
Inpatient Management of Opioid Use Disorder: Methadone vs Buprenorphine - Comparison Table

Some patients may decline buprenorphine
Buprenorphine - Comparison Table ... Dosing usually begins ... For IM formulation ... , the dose is usually ... common side effects are
Antiplatelet Conversion - Switching Between Oral P2Y12 Inhibitors
A, Switching between oral agents in the acute/early phase.
Antiplatelet Conversion ... Switching between oral agents ... of patients who are ... the timing and dosing ... Switching between oral agents
Myasthenia Gravis - Summary
 • an autoimmune disease of the postsynaptic neuromuscular junction associated with antibodies
Disease-specific antibodies are ... exacerbation at high doses ... immunosuppressant agents ... generalized MG who are ... Hospital of Baltimore IM